TSXV - Delayed Quote CAD

Thiogenesis Therapeutics, Corp. (TTI.V)

Compare
0.5700
-0.0100
(-1.72%)
At close: January 10 at 2:08:32 PM EST
Currency in CAD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
2/28/2022
12/31/2021
Operating Expense
4,388.5100
5,206.0210
1,974.8470
224.6780
1,279.0660
Operating Income
-4,388.5100
-5,206.0210
-1,974.8470
-224.6780
-1,279.0660
Net Non Operating Interest Income Expense
201.7200
171.1650
2.0580
0.2210
-3.0030
Other Income Expense
96.6480
-28.1550
-1,951.4620
--
63.8070
Pretax Income
-4,090.1420
-5,063.0110
-3,924.2510
-224.4570
-1,218.2620
Net Income Common Stockholders
-4,090.1420
-5,063.0110
-3,924.2510
-224.4570
-1,218.2620
Diluted NI Available to Com Stockholders
-4,090.1420
-5,063.0110
-3,924.2510
-224.4570
-1,218.2620
Basic EPS
-0.09
-0.13
-0.16
-0.01
-0.04
Diluted EPS
-0.09
-0.13
-0.16
-0.01
-0.04
Basic Average Shares
43,904.6060
39,129.3340
25,291.5540
27,910.1750
27,910.1750
Diluted Average Shares
43,904.6060
39,129.3340
25,291.5540
27,910.1750
27,910.1750
Total Expenses
4,388.5100
5,206.0210
1,974.8470
224.6780
1,279.0660
Net Income from Continuing & Discontinued Operation
-4,090.1420
-5,063.0110
-3,924.2510
-224.4570
-1,218.2620
Normalized Income
-4,186.7900
-5,034.8560
-3,980.4420
-224.4570
-1,282.0690
Interest Income
201.7200
171.1650
6.1810
0.2470
--
Interest Expense
--
--
4.1230
0.0260
3.0030
Net Interest Income
201.7200
171.1650
2.0580
0.2210
-3.0030
EBIT
-4,245.5000
-5,063.0110
-3,920.1280
-224.4310
-1,215.2590
EBITDA
-4,245.5000
-5,063.0110
-3,920.1280
-224.4310
-1,215.2590
Net Income from Continuing Operation Net Minority Interest
-4,090.1420
-5,063.0110
-3,924.2510
-224.4570
-1,218.2620
Total Unusual Items Excluding Goodwill
96.6480
-28.1550
56.1910
--
63.8070
Total Unusual Items
96.6480
-28.1550
56.1910
--
63.8070
Normalized EBITDA
-4,342.1480
-5,034.8560
-3,976.3190
-224.4310
-1,279.0660
12/31/2021 - 4/13/2022

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

NWRN.SW Newron Pharmaceuticals S.p.A.
8.88
+1.72%
 
SANN.SW Santhera Pharmaceuticals Holding AG
13.68
-2.84%
 
RLF.SW Relief Therapeutics Holding SA
3.8500
-1.53%
 
RKV.V Rakovina Therapeutics Inc.
0.1750
-2.78%
 
IDIA.SW Idorsia Ltd
0.7790
-1.77%
 
GBIO Generation Bio Co.
0.9255
+1.69%
 
BOLT Bolt Biotherapeutics, Inc.
0.5387
-4.69%
 
SVA.TO Sernova Corp.
0.2250
0.00%
 
NCNA NuCana plc
1.1300
-1.74%
 
PBM Psyence Biomedical Ltd.
1.7000
-7.61%